Publication: China Brief Volume: 21 Issue: 5
March 15, 2021 02:23 PM
Age: 3 weeks
Image: Chinese President Xi Jinping attends a welcome ceremony held by Nepali President Bidya Devi Bhandari upon arriving in Kathmandu for a state visit on Nepal 12, 2019. Xi was the first Chinese president to visit Nepal in over 20 years. (Image source: Xinhua)
Introduction
Commonly held economic theory generally suggests that foreign aid benefits the recipient. But so far, China’s bilateral relations with Nepal which are based upon generous pledges of foreign direct investment (FDI) have created a power imbalance. China’s outsized influence in Nepal was most recently highlighted by overt Chinese involvement in a recent constitutional crisis that split the ruling Nepal Communist Party (NCP). A week after Prime Minister Khagda Prasad Sharma Oli dissolved the Parliament on December 20, a delegation led by Guo Yezhou, vice minister of the Chinese Communist Party (CCP) International Liaison Depart
Qatar Police Recruit Nepali Citizens, Leaving Kathmandu Out of the Loop
There is an urgent need for Nepal to sign a formal agreement with Qatar in order to safeguard the interests of its workers in that country.
March 12, 2021
Nepali workers being interviewed by the International Labor Organization’s Employment Services Center, 2016.
Credit: Flickr/International Labour Organization ILO
Advertisement
Local reports reveal that Qatar has initiated the illegal recruitment of 12,000 Nepali citizens for its police force in the run-up to the 2022 soccer World Cup in the country.
Nepal’s government forbids its citizens from serving in Qatar’s security agencies as no formal agreement exists. The Nepali embassy in Qatar has sent a letter to the country’s foreign ministry regarding the issue but no decision has been made.
Chinese vaccine Sinopharm has not yet completed phase 3 clinical trials. Sri Lanka will depend mostly on the AstraZeneca vaccine
Key Highlights
World Health Organisation (WHO) is yet to approve Sinopharm vaccine
Sri Lankan cabinet approved purchase of 10 million doses of Made in India AstraZeneca s COVID-19 vaccine
Sri Lanka will depend on the AstraZeneca vaccine from the Serum Institute of India
New Delhi: In a big blow for China, Sri Lanka has put the Chinese Sinopharm’s COVID-19 vaccine on hold and will now use India-made Oxford AstraZeneca vaccine to inoculate 14 million people.
Cabinet co-spokesman, Dr Ramesh Pathirana told Daily Mirror that the Chinese vaccine Sinopharm has not yet completed phase 3 clinical trials.
Sri Lanka puts Chinese COVID-19 vaccine on hold
Sun Online Desk
27th February, 2021 10:40:42
In a big blow for China, Sri Lanka has put the Chinese Sinopharm’s COVID-19 vaccine on hold and will now use India-made Oxford AstraZeneca vaccine to inoculate 14 million people.
Cabinet co-spokesman, Dr Ramesh Pathirana told Daily Mirror that the Chinese vaccine Sinopharm has not yet completed phase 3 clinical trials.
He further said that a complete dossier related to the registration of the Chinese vaccine has also not yet been received.
Sri Lanka to rely on India-made AstraZeneca vaccine
Sri Lanka will depend mostly on the AstraZeneca vaccine from the Serum Institute of India, he added.
Sri Lanka puts Chinese COVID-19 vaccine on hold, will use India-made shot to inoculate 14 million people keralakaumudi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from keralakaumudi.com Daily Mail and Mail on Sunday newspapers.